PI3K and mTOR inhibitors - a new generation of targeted anticancer agents

被引：100

作者：

Brachmann, Saskia ^{[1
]}

Fritsch, Christine ^{[1
]}

Maira, Saveur-Michel ^{[1
]}

Garcia-Echeverria, Carlos ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, Basel, Switzerland

来源：

CURRENT OPINION IN CELL BIOLOGY | 2009年 / 21卷 / 02期

关键词：

PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET; RAPAMYCIN INHIBITOR; DRUG DISCOVERY; PATHWAY; KINASE; CANCER; ACTIVATION; NVP-BEZ235; ANTITUMOR; GROWTH;

D O I：

10.1016/j.ceb.2008.12.011

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Epidemiological and experimental studies support an important role of the phosphoinosite 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) pathway in the biology of human cancers. Over the past few years a number of components of this signaling cascade have been the subject of intense drug discovery activities. This article summarizes progress made in the identification of kinase inhibitors of PI3K and mTOR, with an emphasis placed on drugs currently undergoing clinical trials. Potential combination strategies, safety concerns, and resistance mechanisms for this new generation of anticancer agents are also discussed.

引用

页码：194 / 198

页数：5

共 40 条

[1] Structural comparisons of class I phosphoinositide 3-kinases [J].

Amzel, L. Mario ;

Huang, Chuan-Hsiang ;

Mandelker, Diana ;

Lengauer, Christoph ;

Gabelli, Sandra B. ;

Vogelstein, Bert .

NATURE REVIEWS CANCER, 2008, 8 (09) :665-669

[2] Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis [J].

Bissler, John J. ;

McCormack, Francis X. ;

Young, Lisa R. ;

Elwing, Jean M. ;

Chuck, Gail ;

Leonard, Jennifer M. ;

Schmithorst, Vincent J. ;

Laor, Tal ;

Brody, Alan S. ;

Bean, Judy ;

Salisbury, Shelia ;

Franz, David N. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (02) :140-151

[3] The TOR pathway: A target for cancer therapy [J].

Bjornsti, MA ;

Houghton, PJ .

NATURE REVIEWS CANCER, 2004, 4 (05) :335-348

[4] The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications [J].

Carnero, Amancio ;

Blanco-Aparicio, Carmen ;

Renner, Oliver ;

Link, Wolfgang ;

Leal, Juan F. M. .

CURRENT CANCER DRUG TARGETS, 2008, 8 (03) :187-198

[5] The PTEN-PI3K pathway: of feedbacks and cross-talks [J].

Carracedo, A. ;

Pandolfi, P. P. .

ONCOGENE, 2008, 27 (41) :5527-5541

[6]

Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]

[7] Phosphoinositide 3-Kinase p110β Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development [J].

Ciraolo, Elisa ;

Iezzi, Manuela ;

Marone, Romina ;

Marengo, Stefano ;

Curcio, Claudia ;

Costa, Carlotta ;

Azzolino, Ornella ;

Gonella, Cristiano ;

Rubinetto, Cristina ;

Wu, Haiyan ;

Dastru, Walter ;

Martin, Erica L. ;

Silengo, Lorenzo ;

Altruda, Fiorella ;

Turco, Emilia ;

Lanzetti, Letizia ;

Musiani, Piero ;

Rueckle, Thomas ;

Rommel, Christian ;

Backer, Jonathan M. ;

Forni, Guido ;

Wymann, Matthias P. ;

Hirsch, Emilio .

SCIENCE SIGNALING, 2008, 1 (36)

[8] Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers [J].

Engelman, Jeffrey A. ;

Chen, Liang ;

Tan, Xiaohong ;

Crosby, Katherine ;

Guimaraes, Alexander R. ;

Upadhyay, Rabi ;

Maira, Michel ;

McNamara, Kate ;

Perera, Samanthi A. ;

Song, Youngchul ;

Chirieac, Lucian R. ;

Kaur, Ramneet ;

Lightbown, Angela ;

Simendinger, Jessica ;

Li, Timothy ;

Padera, Robert F. ;

Garcia-Echeverria, Carlos ;

Weissleder, Ralph ;

Mahmood, Umar ;

Cantley, Lewis C. ;

Wong, Kwok-Kin .

NATURE MEDICINE, 2008, 14 (12) :1351-1356

[9] mTOR inhibitors in the treatment of cancer [J].

Fasolo, Angelica ;

Sessa, Cristiana .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (11) :1717-1734

[10] The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer [J].

Folkes, Adrian J. ;

Ahmadi, Khatereh ;

Alderton, Wendy K. ;

Alix, Sonia ;

Baker, Stewart J. ;

Box, Gary ;

Chuckowree, Irina S. ;

Clarke, Paul A. ;

Depledge, Paul ;

Eccles, Suzanne A. ;

Friedman, Lori S. ;

Hayes, Angela ;

Hancox, Timothy C. ;

Kugendradas, Arumugam ;

Lensun, Letitia ;

Moore, Pauline ;

Olivero, Alan G. ;

Pang, Jodie ;

Patel, Sonal ;

Pergl-Wilson, Giles H. ;

Raynaud, Florence I. ;

Robson, Anthony ;

Saghir, Nahid ;

Salphati, Laurent ;

Sohal, Sukhjit ;

Ultsch, Mark H. ;

Valenti, Melanie ;

Wallweber, Heidi J. A. ;

Wan, Nan Chi ;

Wiesmann, Christian ;

Workman, Paul ;

Zhyvoloup, Alexander ;

Zvelebil, Marketa J. ;

Shuttleworth, Stephen J. .

JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (18) :5522-5532

← 1 2 3 4 →